Ad is loading...
BVNKF
Price
$29.32
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
LABFF
Price
$90.61
Change
-$0.00 (-0.00%)
Updated
Jul 1 closing price
Ad is loading...

BVNKF vs LABFF

Header iconBVNKF vs LABFF Comparison
Open Charts BVNKF vs LABFFBanner chart's image
Bavarian Nordic A/S
Price$29.32
Change-$0.00 (-0.00%)
Volume$163
CapitalizationN/A
LABORATORIOS FARMACEUTICOS ROVI SA
Price$90.61
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
BVNKF vs LABFF Comparison Chart
Loading...
View a ticker or compare two or three
VS
BVNKF vs. LABFF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVNKF is a Buy and LABFF is a Buy.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BVNKF: $29.33 vs. LABFF: $90.61)
Brand notoriety: BVNKF and LABFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVNKF: 17% vs. LABFF: 100%
Market capitalization -- BVNKF: $2.28B vs. LABFF: $3.36B
BVNKF [@Biotechnology] is valued at $2.28B. LABFF’s [@Biotechnology] market capitalization is $3.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVNKF’s FA Score shows that 1 FA rating(s) are green whileLABFF’s FA Score has 2 green FA rating(s).

  • BVNKF’s FA Score: 1 green, 4 red.
  • LABFF’s FA Score: 2 green, 3 red.
According to our system of comparison, LABFF is a better buy in the long-term than BVNKF.

Price Growth

BVNKF (@Biotechnology) experienced а -0.99% price change this week, while LABFF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
LABFF($3.36B) has a higher market cap than BVNKF($2.28B). LABFF has higher P/E ratio than BVNKF: LABFF (28.85) vs BVNKF (23.01). LABFF YTD gains are higher at: 74.250 vs. BVNKF (11.821). BVNKF has higher annual earnings (EBITDA): 1.42B vs. LABFF (218M). BVNKF has more cash in the bank: 2.24B vs. LABFF (44.6M). LABFF (121M) and BVNKF (125M) have identical debt. BVNKF has higher revenues than LABFF: BVNKF (6.08B) vs LABFF (778M).
BVNKFLABFFBVNKF / LABFF
Capitalization2.28B3.36B68%
EBITDA1.42B218M649%
Gain YTD11.82174.25016%
P/E Ratio23.0128.8580%
Revenue6.08B778M782%
Total Cash2.24B44.6M5,016%
Total Debt125M121M103%
FUNDAMENTALS RATINGS
BVNKF: Fundamental Ratings
BVNKF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
76
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSZIX18.320.08
+0.44%
Cohen & Steers Real Estate Securities Z
PGRVX9.690.01
+0.10%
Principal Global Real Estate Sec R4
MDDIX10.860.01
+0.09%
MassMutual Diversified Value I
KSMIX10.66-0.10
-0.93%
Keeley Small-Mid Cap Value I
NEEGX59.52-1.55
-2.54%
Needham Growth Retail

BVNKF and

Correlation & Price change

A.I.dvisor tells us that BVNKF and LABFF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVNKF and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVNKF
1D Price
Change %
BVNKF100%
N/A
LABFF - BVNKF
24%
Poorly correlated
N/A
SILO - BVNKF
22%
Poorly correlated
-1.74%
GOVX - BVNKF
22%
Poorly correlated
-6.90%
MBXBF - BVNKF
21%
Poorly correlated
N/A
IMRN - BVNKF
20%
Poorly correlated
-6.22%
More

LABFF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LABFF has been closely correlated with IMRN. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if LABFF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LABFF
1D Price
Change %
LABFF100%
N/A
IMRN - LABFF
81%
Closely correlated
-6.22%
MNMD - LABFF
47%
Loosely correlated
-7.51%
CELZ - LABFF
35%
Loosely correlated
+1.50%
NVO - LABFF
29%
Poorly correlated
-3.40%
QSI - LABFF
26%
Poorly correlated
-5.77%
More